Drag

Pfizer Limited

Healthcare PFIZER

4751.40INR
83.80 ( 1.80%)

Last update at

Day Range

4629.104756.50
LowHigh

52 Week Range

3596.63 5873.50
LowHigh

Fundamentals

  • Previous Close 4667.60
  • Market Cap 222237.90M
  • Volume8,502
  • P/E Ratio 26.50
  • EBITDA 7783.70M
  • Revenue TTM 23752.90M
  • Revenue Per Share TTM 519.24
  • Gross Profit TTM 15317.10M
  • Diluted EPS TTM 183.33

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 10160.90M 7460.70M 8240.10M 7728.90M 6687.20M
Net income 7676.00M 5513.30M 6239.30M 6125.60M 4976.10M
Total Revenue 22813.50M 21931.70M 24247.60M 26105.50M 22384.30M
Gross Profit 14655.40M 13948.90M 15510.90M 16625.20M 14406.90M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 49111.10M 42287.80M 40007.30M 39005.10M 32659.00M
Intangible assets 243.10M 342.70M 442.30M 945.50M 1448.70M
Other current assets 428.60M 1209.90M 414.40M 17.10M 1491.60M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 3830.70M 754.00M -261.60M -884.50M -16125.80M
Operating Cash 6597.50M 2568.40M 3556.80M 6670.80M 4273.30M
Free Cash Flow 6316.00M 2379.10M 2907.00M 6517.70M 4096.30M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - General

Company Change Price Market Cap (M) P/E Ratio
PFIZER
Pfizer Limited 		83.80 1.80% 4751.40 222237.90 26.50
GLAXO
GlaxoSmithKline Pharmaceuticals Limited 		-22.40 -0.92% 2412.90 406354.23 42.58
SANOFICONR
SANOFI CONS HEALTHC IND L 		-97.90 -2.23% 4291.00 101612.67 46.61
SANOFI
Sanofi India Limited 		22.40 0.56% 4037.60 95811.08 26.88
MARKSANS
Marksans Pharma Limited 		-2.46 -1.37% 177.58 81052.87 23.02

Profile

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.

Pfizer Limited

The Capital, 1802/1901, Mumbai, India, 400051

Key Executives

Name Title Year Born
Mr. Sridhar Subramaniam CEO, MD, Lead of Essential Health Portfolio & Director 1968
Mr. Milind Anil Patil CFO, Exec. Director of Fin. & Whole-time Director 1964
Mr. Samir Salauddin Kazi Exec. Director of Legal & Exec. Director 1975
Mr. Prajeet Nair C.S. Compliance Officer & Company Sec. NA
Mr. Sharad Goswami Sr. Director of Policy & Public Affairs NA
Ms. Shilpi Singh Director of People Experience NA
Ms. Meenakshi Nevatia MD, CEO & Director 1970
Mr. Prajeet Nair C.S. Director of Corporate Services, Company Secretary & Compliance Officer NA
Mr. Pazhania Pillai Rengan Whole-Time Director & Executive Director of Plant Operations 1979
Mr. Anil Pattanshetty Senior Director of Business Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.